3 unknown, 2 completed. 4 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 3, Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow William Ondo, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pitolisant in Refractory Restless Legs Syndrome Pitolisant - Restless Legs Syndrome | Phase 4 | Unknown | William Ondo, MD | 18 | 2022-09-20 | 2022-10-14 |
| Sublingual Apomorphine in Refractory Restless Legs Syndrome Apomorphine Sublingual Film, Placebo - Restless Legs Syndrome | Phase 4 | Unknown | William Ondo, MD | 16 | 2022-09-01 | 2022-09-06 |
| Brain Perfusion & Oxygenation in Parkinson's Disease With NOH Droxidopa, Placebo - Parkinson Disease, Neurogenic Orthostatic Hypotension | Phase 4 | Completed | William Ondo, MD | 17 | 2018-08-23 | 2022-09-06 |
| A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine) Tetrabenazine - Huntington's Disease | Phase 4 | Unknown | William Ondo, MD | 20 | 2018-08-01 | 2022-09-02 |
| Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist Ecopipam, Placebo - Restless Legs Syndrome, Augmentation | Phase 1 / Phase 2 | Completed | William Ondo, MD | 10 | 2017-09-18 | 2026-04-27 |
Restless Legs Syndrome (3) · Huntington Disease (1) · Parkinson Disease (1)
Sugars (2) · Droxidopa (1) · Tetrabenazine (1) · ecopipam (1) · pitolisant (1)
United States (5)
William G Ondo, MD (1) · William G. Ondo, MD (1)